Literature DB >> 25326589

Hepatic Mitochondrial Alteration in CD-1 Mice Associated with Prenatal Exposures to Low Doses of Perfluorooctanoic Acid (PFOA).

Erin M Quist1, Adam J Filgo2, Connie A Cummings3, Grace E Kissling4, Mark J Hoenerhoff5, Suzanne E Fenton6.   

Abstract

Perfluorooctanoic acid (PFOA) is a perfluoroalkyl acid primarily used as an industrial surfactant. It persists in the environment and has been linked to potentially toxic and/or carcinogenic effects in animals and people. As a known activator of peroxisome proliferator-activated receptors (PPARs), PFOA exposure can induce defects in fatty acid oxidation, lipid transport, and inflammation. Here, pregnant CD-1 mice were orally gavaged with 0, 0.01, 0.1, 0.3, and 1 mg/kg of PFOA from gestation days (GD) 1 through 17. On postnatal day (PND) 21, histopathologic changes in the livers of offspring included hepatocellular hypertrophy and periportal inflammation that increased in severity by PND 91 in an apparent dose-dependent response. Transmission electron microscopy (TEM) of selected liver sections from PND 91 mice revealed PFOA-induced cellular damage and mitochondrial abnormalities with no evidence of peroxisome proliferation. Within hypertrophied hepatocytes, mitochondria were not only increased in number but also exhibited altered morphologies suggestive of increased and/or uncontrolled fission and fusion reactions. These findings suggest that peroxisome proliferation is not a component of PFOA-induced hepatic toxicity in animals that are prenatally exposed to low doses of PFOA.
© 2014 by The Author(s).

Entities:  

Keywords:  PFOA; PPARα; hepatocellular hypertrophy; liver; mitochondrial damage; mouse; peroxisome proliferation

Mesh:

Substances:

Year:  2014        PMID: 25326589      PMCID: PMC4400180          DOI: 10.1177/0192623314551841

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  18 in total

1.  Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Authors:  Adam J Filgo; Erin M Quist; Mark J Hoenerhoff; Amy E Brix; Grace E Kissling; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-11-14       Impact factor: 1.902

Review 2.  Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop.

Authors:  A P Hall; C R Elcombe; J R Foster; T Harada; W Kaufmann; A Knippel; K Küttler; D E Malarkey; R R Maronpot; A Nishikawa; T Nolte; A Schulte; V Strauss; M J York
Journal:  Toxicol Pathol       Date:  2012-06-21       Impact factor: 1.902

3.  Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid.

Authors:  Qian Yang; Manuchehr Abedi-Valugerdi; Yi Xie; Xiao-Yan Zhao; Göran Möller; B Dean Nelson; Joseph W DePierre
Journal:  Int Immunopharmacol       Date:  2002-02       Impact factor: 4.932

4.  Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Authors:  Madisa B Macon; LaTonya R Villanueva; Katoria Tatum-Gibbs; Robert D Zehr; Mark J Strynar; Jason P Stanko; Sally S White; Laurence Helfant; Suzanne E Fenton
Journal:  Toxicol Sci       Date:  2011-04-11       Impact factor: 4.849

Review 5.  Polyfluorinated compounds: past, present, and future.

Authors:  Andrew B Lindstrom; Mark J Strynar; E Laurence Libelo
Journal:  Environ Sci Technol       Date:  2011-09-09       Impact factor: 9.028

6.  Ultrastructural pathology and interorganelle cross talk in hepatotoxicity.

Authors:  Norman F Cheville
Journal:  Toxicol Pathol       Date:  2013-01-23       Impact factor: 1.902

7.  Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study.

Authors:  Qingyu Huang; Jie Zhang; Francis L Martin; Siyuan Peng; Meiping Tian; Xiaoli Mu; Heqing Shen
Journal:  Toxicol Lett       Date:  2013-09-12       Impact factor: 4.372

Review 8.  Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature.

Authors:  Gloria B Post; Perry D Cohn; Keith R Cooper
Journal:  Environ Res       Date:  2012-05-04       Impact factor: 6.498

Review 9.  Perfluorinated compounds.

Authors:  Christopher Lau
Journal:  Exp Suppl       Date:  2012

10.  Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure.

Authors:  Valentina Gallo; Giovanni Leonardi; Bernd Genser; Maria-Jose Lopez-Espinosa; Stephanie J Frisbee; Lee Karlsson; Alan M Ducatman; Tony Fletcher
Journal:  Environ Health Perspect       Date:  2012-01-30       Impact factor: 9.031

View more
  14 in total

1.  Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review.

Authors:  Brianna N VanNoy; Juleen Lam; Ami R Zota
Journal:  Curr Environ Health Rep       Date:  2018-06

2.  Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.

Authors:  Kaberi P Das; Carmen R Wood; Mimi T Lin; Anatoly A Starkov; Christopher Lau; Kendall B Wallace; J Christopher Corton; Barbara D Abbott
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

Review 3.  Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease.

Authors:  Lindsey S Treviño; Tiffany A Katz
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

Review 4.  Mitochondrial fusion, fission, and mitochondrial toxicity.

Authors:  Joel N Meyer; Tess C Leuthner; Anthony L Luz
Journal:  Toxicology       Date:  2017-08-05       Impact factor: 4.221

5.  Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines.

Authors:  John Bassler; Alan Ducatman; Meenal Elliott; Sijin Wen; Banrida Wahlang; John Barnett; Matthew C Cave
Journal:  Environ Pollut       Date:  2019-01-18       Impact factor: 8.071

Review 6.  Toward a Mechanistic Understanding of Poly- and Perfluoroalkylated Substances and Cancer.

Authors:  Raya I Boyd; Saeed Ahmad; Ratnakar Singh; Zeeshan Fazal; Gail S Prins; Zeynep Madak Erdogan; Joseph Irudayaraj; Michael J Spinella
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

7.  Adverse bioeffect of perfluorooctanoic acid on liver metabolic function in mice.

Authors:  Xinmou Wu; Guojie Xie; Xiaoxiao Xu; Wei Wu; Bin Yang
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-02       Impact factor: 4.223

8.  An 'Omics Approach to Unraveling the Paradoxical Effect of Diet on Perfluorooctanesulfonic Acid (PFOS) and Perfluorononanoic Acid (PFNA)-Induced Hepatic Steatosis.

Authors:  Marisa Pfohl; Emily Marques; Adam Auclair; Benjamin Barlock; Rohitash Jamwal; Michael Goedken; Fatemeh Akhlaghi; Angela L Slitt
Journal:  Toxicol Sci       Date:  2021-04-12       Impact factor: 4.849

Review 9.  Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.

Authors:  Suzanne E Fenton; Alan Ducatman; Alan Boobis; Jamie C DeWitt; Christopher Lau; Carla Ng; James S Smith; Stephen M Roberts
Journal:  Environ Toxicol Chem       Date:  2020-12-07       Impact factor: 4.218

10.  Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children.

Authors:  Nikos Stratakis; David V Conti; Ran Jin; Katerina Margetaki; Damaskini Valvi; Alexandros P Siskos; Léa Maitre; Erika Garcia; Nerea Varo; Yinqi Zhao; Theano Roumeliotaki; Marina Vafeiadi; Jose Urquiza; Silvia Fernández-Barrés; Barbara Heude; Xavier Basagana; Maribel Casas; Serena Fossati; Regina Gražulevičienė; Sandra Andrušaitytė; Karan Uppal; Rosemary R C McEachan; Eleni Papadopoulou; Oliver Robinson; Line Småstuen Haug; John Wright; Miriam B Vos; Hector C Keun; Martine Vrijheid; Kiros T Berhane; Rob McConnell; Lida Chatzi
Journal:  Hepatology       Date:  2020-10-19       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.